Gala Therapeutics Overview
- Founded
- 2015
- Status
- Private
- Employees
- 29
- Latest Deal Type
- Series A
- Latest Deal Amount
- $42.5M
- Investors
- 1
Gala Therapeutics General Information
Description
Developer of disease modifying therapies intended to improve survival, quality of life and outcomes for patients with lung cancer, COPD, asthma and other pulmonary diseases. The company's therapies address the needs of interventional pulmonologists, thoracic surgeons and all physicians who treat pulmonary disease, enabling physicians to treat their patients better, resulting in a better medical outcome.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
- 1531 Industrial Road
- Suite 100
- San Carlos, CA 94070
- United States
+1 (650) 000-0000
Gala Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 18-Nov-2019 | $42.5M | 000.00 | Completed | Generating Revenue |
Gala Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 00.000 |
Gala Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of disease modifying therapies intended to improve survival, quality of life and outcomes for patients with lu
Therapeutic Devices
San Carlos, CA
29
As of 2020
000.00
00000000000
000.00
0000000
didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
00000000000 0000000
Minneapolis, MN
00
As of 0000
00000
0000000000 0
00000
00000000
et, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
00000000000 0000000
Lexington, MA
00
As of 0000
00000
000000000 -
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialGala Therapeutics Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nuvaira | Venture Capital-Backed | Minneapolis, MN | 00 | 00000 | 0000000000 0 | 00000 |
| 0000000000 | Venture Capital-Backed | Lexington, MA | 00 | 00000 | 000000000 - | 00000 |
Gala Therapeutics Executive Team (4)
Gala Therapeutics Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jonathan Waldstreicher MD | Self | Founder, Chief Executive Officer, President & Board Member | 000 0000 |
| Seth Harrison MD | Self | Board Member | 000 0000 |
Gala Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGala Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Apple Tree Partners | Venture Capital | Minority | 000 0000 | 000000 0 |